Novotech

News

Union therapy-A Preventive medicine model to combat COVID-19 and future threats

Kanishk Kala1 Rupinder Kaur Sodhi2 CCP Mohali IK Gujral PTU COVID-19 has become a global threat with immense mortality and morbidity in India.1The efforts of scientists are in line to give a concrete solution for the problem. The vaccine has...

Ashfield Engage acquires Nuvera to enhance Patient Solutions offering

Ashfield Engage, part of UDG Healthcare plc., announces the acquisition of Nuvera LLC, a US-based healthcare consulting firm specializing in patient support programs has complete. Nuvera are experts in optimizing the design and build of seamless patient and HCP treatment...

India’s Biological E. to produce J&J COVID-19 vaccine

India's Biological E. will produce the Johnson & Johnson COVID-19 vaccine alongside its own candidate, which could boost the country's overall supplies amid a shortage. "The infrastructure and plants are completely separate for both the products and we will be...

Peli BioThermal Expands Role for Dominic Hyde to Include Global Services

Peli BioThermal, the global name in temperature controlled packaging solutions,announces Dominic Hyde in his new role as Vice President of Global Services. In this role, Hyde will expand his responsibilities to all global services, including the worldwide service network...

Cryoport Expands Global Supply Chain Network with Belgium Acquisition

Cryoport, Inc., a leading global provider of innovative temperature-controlled supply chain solutions to the life sciences including clinical research, pharmaceutical and cell and gene therapy markets, announced the expansion of its global supply chain network with the acquisition of...

Syntegon presents numerous innovations at ACHEMA Pulse

Ever smaller batches for individual therapeutic approaches, new cost-intensive biopharmaceuticals, and the Covid-19 pandemic are currently changing the pharmaceutical industry more rapidly than ever before. Syntegon Technology showcases solutions to these challenges at the virtual ACHEMA Pulse from June...

Gamma Biosciences Acquires Controlling Stake in Mirus Bio to Expand Reach in Gene Therapy and Next Generation Vaccines

Gamma Biosciences, a global life sciences company serving the advanced therapy market, announced that it has agreed to make a controlling investment in Mirus Bio, an innovator and developer of biomimetic, cell-adaptive lipid-polymer nanocomplexes (LPNCs) for nucleic acid delivery...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate ยป